SCHEMBL16346261

SCHEMBL16346261

Nc1ccccc1C#CCO

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.65
CYP3A4 P08684 5/20 0.65
CYP1A2 P05177 4/20 0.65
CYP2C9 P11712 4/20 0.65
CYP2C19 P33261 4/20 0.65
KDM4E B2RXH2 3/20 0.65
MAPT P10636 2/20 0.65
SMN1; SMN2 Q16637 2/20 0.52
HSD17B10 Q99714 2/20 0.52
MEN1 O00255 1/20 0.52
NPC1 O15118 1/20 0.52
HPGD P15428 1/20 0.52
KMT2A Q03164 1/20 0.52
HSP90AA1 P07900 1/20 0.47
NTSR1 P30989 1/20 0.47
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
ALOX15 P16050 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30515632 0.84 CYP1A2 (0.44) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL6449051 0.84 CYP1A2 (0.44) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL23908785 0.83 CYP3A4 (0.77) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL30727473 0.83 CYP3A4 (0.77) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL2929973 0.80 CYP2C19 (0.56) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL12849677 0.79 CYP3A4 (1.00) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL3978730 0.78 CYP3A4 (0.55) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL1922269 0.78 CYP3A4 (0.76) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL30270434 0.77 CYP3A4 (0.55) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL10442103 0.76 FFAR1 (0.41) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120757499-A 3-Methylene-2, 3-dihydro-4-quinolinone derivative and synthetic method and application thereof 上海应用技术大学 2025-10-10 CN disclosed
US-12162863-B2 Modulators of stimulator of interferon genes (STING) Ryvu Therapeutics S.A. (PL) 2024-12-10 US disclosed
US-20220402898-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2022-12-22 US disclosed
US-20220402898-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2022-12-22 US disclosed
EP-3807264-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2021-04-21 EP disclosed
WO-2019238786-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2019-12-19 WO disclosed
WO-2019238786-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) Ryvu Therapeutics S.A. (PL) 2019-12-19 WO disclosed
EP-3017307-B1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING UNIV STRASBOURG (FR) 2018-11-21 EP disclosed
US-10131626-B2 3-aryl propiolonitrile compounds for thiol labeling UNIVERSITE DE STRASBOURG (FR) 2018-11-20 US disclosed
US-20170210700-A1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2017-07-27 US disclosed
US-9663454-B2 3-aryl propiolonitrile compounds for thiol labeling UNIVERSITE DE STRASBOURG (FR) 2017-05-30 US disclosed
US-20160145199-A1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING UNIVERSITE DE STRASBOURG (FR) 2016-05-26 US disclosed
EP-3017307-A1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING Université de Strasbourg (FR) 2016-05-11 EP disclosed
WO-2015001117-A1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING UNIVERSITE DE STRASBOURG (FR) 2015-01-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10131626-B2 3-aryl propiolonitrile compounds for thiol labeling PTMS, TST, PNN ALDH1A1 30/4885CYP3A4 1076/4885CYP1A2 830/4885
US-12162863-B2 Modulators of stimulator of interferon genes (STING) STING1, IRF3, CGAS ALDH1A1 4462/4885CYP3A4 1025/4885CYP1A2 718/4885
US-20170210700-A1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING PTMS, TST, PNN ALDH1A1 30/4885CYP3A4 1076/4885CYP1A2 830/4885
US-20160145199-A1 3-ARYL PROPIOLONITRILE COMPOUNDS FOR THIOL LABELING PTMS, TST, PNN ALDH1A1 30/4885CYP3A4 1076/4885CYP1A2 830/4885
US-20220402898-A1 MODULATORS OF STIMULATOR OF INTERFERON GENES (STING) STING1, IRF3, CGAS ALDH1A1 4462/4885CYP3A4 1025/4885CYP1A2 718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.